C-reactive protein, interleukin-6, soluble tumor necrosis factor α receptor 2 and incident clinical depression

Patricia Chocano-Bedoya; Fariba Mirzaei; Éilis J. O’Reilly; Michel Lucas; Olivia I. Okereke; Frank B Hu; Eric B. Rimm; Alberto Ascherio

doi:10.1016/j.jad.2014.03.023

Related publications

Article1995

Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression

Michael Maes, Herbert Y. Meltzer, Eugène Bosmans, Raf Bergmans, Eric Vandoolaeghe, R. Ranjan, Roger Desnyder

Article2021

Peripheral levels of C-reactive protein, tumor necrosis factor-α, interleukin-6, and interleukin-1β across the mood spectrum in bipolar disorder: A meta-analysis of mean differences and variability

Marco Solmi, Manu Sharma, Emanuele F. Osimo, Michele Fornaro, Beatrice Bortolato, Giovanni Croatto, Alessandro Miola, Eduard Vieta, Carmine M. Pariante, Lee Smith, Paolo Fusar‐Poli, Jae Il Shin, Michael Berk, André F. Carvalho

Article2000

Prognostic Value of Cytokine Concentrations (Tumor Necrosis Factor–α, Interleukin‐6, and Interleukin‐10) and Clinical Parameters in Severe Melioidosis

Andrew J. H. Simpson, Michael D. Smith, Gerrit Jan Weverling, Yupin Suputtamongkol, Brian Angus, Wipada Chaowagul, Sir Nicholas White, Sander J. H. van Deventer, Jan M. Prins

The Journal of Infectious Diseases

Article2008

Interleukin-6 Receptor Gene, Plasma C-Reactive Protein, and Diabetes Risk in Women

Lu Qi, Nader Rifai, Frank B Hu

Article2021

Modulating inflammation through the neutralization of Interleukin-6 and tumor necrosis factor-α by biofunctionalized nanoparticles

Ana Cláudia Lima, Diana Amorim, Inês Martins Laranjeira, Armando Almeida, Rui L Reis, Helena Ferreira, Filipa Pinto‐Ribeiro, Nuno M. Neves